Silexion Therapeutics Corp Gains 96.95%
Wed, May 20, 2026 at 07:41 PM
Silexion Therapeutics Corp (SLXN:NASDAQ) shot up at $0.53, representing a gain of 97%. On Wed, May 20, 2026, SLXN:NASDAQ touched a New 2-Week Intraday High of $0.67. The stock appeared on our News Catalysts scanner on Mon, May 18, 2026 at 10:07 AM in the 'INVESTOR UPDATE' category. From Wed, May 06, 2026, the stock recorded 30.00% Up Days and 9.09% Green Days
The stock spiked on Wed, May 20, 2026 at $0.67 with a volume of 325M+.
About Silexion Therapeutics Corp (SLXN:NASDAQ)
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
Top 10 Gainers:
- HCW Biologics Inc. (HCWB:NASDAQ), 129.25%
- Silexion Therapeutics Corp (SLXN:NASDAQ), 96.95%
- GCL Global Holdings Ltd (GCL:NASDAQ), 72.46%
- BiomX Inc. (PHGE:NYSEMKT), 59.6%
- MetaVia Inc. (MTVA:NASDAQ), 53.72%
- Micware Co. Ltd. (MWC:NASDAQ), 51.48%
- TDH Holdings, Inc. (PETZ:NASDAQ), 41.98%
- MicroAlgo Inc. (MLGO:NASDAQ), 39.95%
- Immunovant, Inc. (IMVT:NASDAQ), 35.26%
- Rain Enhancement Technologies Holdco, Inc. (RAIN:NASDAQ), 34.67%